Cardiac magnetic resonance (CMR) and echocardiographic assessment of paravalvular regurgitation (PVR)
| . | Study population (n = 77) . |
|---|---|
| Days after TAVR | 41 ± 14 |
| Flow measurements | |
| Forward volume, mL | 77.8 ± 19.0 |
| Regurgitant volume, mL | 10.1 ± 8.5 |
| Regurgitant fraction, % | 12.4 ± 9.3 |
| CMR-RF classification | |
| CMR-RF > 20%, n (%) | 15 (19.5) |
| CMR-RF ≤ 20%, n (%) | 62 (80.5) |
| TTE classification of PVRa | |
| None/trace, n (%) | 41 (53.2) |
| Mild, n (%) | 34 (44.2) |
| Moderate, n (%) | 2 (2.6) |
| Severe, n (%) | 0 |
| . | Study population (n = 77) . |
|---|---|
| Days after TAVR | 41 ± 14 |
| Flow measurements | |
| Forward volume, mL | 77.8 ± 19.0 |
| Regurgitant volume, mL | 10.1 ± 8.5 |
| Regurgitant fraction, % | 12.4 ± 9.3 |
| CMR-RF classification | |
| CMR-RF > 20%, n (%) | 15 (19.5) |
| CMR-RF ≤ 20%, n (%) | 62 (80.5) |
| TTE classification of PVRa | |
| None/trace, n (%) | 41 (53.2) |
| Mild, n (%) | 34 (44.2) |
| Moderate, n (%) | 2 (2.6) |
| Severe, n (%) | 0 |
Data are presented as mean ± standard deviation or as number (%).
CMR-RF, cardiac magnetic resonance-regurgitant fraction; TAVR, transcatheter aortic valve replacement; TTE, transthoracic echocardiography.
TTE was performed on the same day as CMR.
Cardiac magnetic resonance (CMR) and echocardiographic assessment of paravalvular regurgitation (PVR)
| . | Study population (n = 77) . |
|---|---|
| Days after TAVR | 41 ± 14 |
| Flow measurements | |
| Forward volume, mL | 77.8 ± 19.0 |
| Regurgitant volume, mL | 10.1 ± 8.5 |
| Regurgitant fraction, % | 12.4 ± 9.3 |
| CMR-RF classification | |
| CMR-RF > 20%, n (%) | 15 (19.5) |
| CMR-RF ≤ 20%, n (%) | 62 (80.5) |
| TTE classification of PVRa | |
| None/trace, n (%) | 41 (53.2) |
| Mild, n (%) | 34 (44.2) |
| Moderate, n (%) | 2 (2.6) |
| Severe, n (%) | 0 |
| . | Study population (n = 77) . |
|---|---|
| Days after TAVR | 41 ± 14 |
| Flow measurements | |
| Forward volume, mL | 77.8 ± 19.0 |
| Regurgitant volume, mL | 10.1 ± 8.5 |
| Regurgitant fraction, % | 12.4 ± 9.3 |
| CMR-RF classification | |
| CMR-RF > 20%, n (%) | 15 (19.5) |
| CMR-RF ≤ 20%, n (%) | 62 (80.5) |
| TTE classification of PVRa | |
| None/trace, n (%) | 41 (53.2) |
| Mild, n (%) | 34 (44.2) |
| Moderate, n (%) | 2 (2.6) |
| Severe, n (%) | 0 |
Data are presented as mean ± standard deviation or as number (%).
CMR-RF, cardiac magnetic resonance-regurgitant fraction; TAVR, transcatheter aortic valve replacement; TTE, transthoracic echocardiography.
TTE was performed on the same day as CMR.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
